How do Older Adults and Caregivers Feel About Their Medications?

April 3, 2018 updated by: Kua Chong Han, Monash University

Patients' and Caregivers' Attitudes Towards Deprescribing in the Asian Community Setting

The aim of this study is to study patients' and caregivers' perspectives towards deprescribing using the Revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

1057

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore
        • Multi-centres

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Potential participants will be selected by convenient sampling from walk-in patients/caregivers who present at the participating pharmacies seeking advice or medication.

Description

Inclusion Criteria:

  • Older adults' inclusion criteria:

    • age at least 65 years;
    • taking one or more long-term prescription medication;
    • have not participated in this anonymous questionnaire previously
  • Caregivers' inclusion criteria:

    • currently an informal caregiver for an older adult (defined as having any role in a family member or friend's management of health and/or medications);
    • care recipient must be at least 65 years of age and taking one or more long-term prescription medication;
    • have not participated in this anonymous questionnaire previously

Exclusion Criteria:

  • Older adults' exclusion criteria:

    • inability to complete a questionnaire in English.
  • Caregivers' exclusion criteria:

    • caregiver's age less than 21 years;
    • caregiver's inability to complete a questionnaire in English.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Older adults
A 5-point Likert scale questionnaire consisting of 22 questions for older adults, and 19 questions of caregivers.
Caregivers
A 5-point Likert scale questionnaire consisting of 22 questions for older adults, and 19 questions of caregivers.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
rPATD questionnaire scorings
Time Frame: up to 9 months
up to 9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 25, 2017

Primary Completion (Actual)

March 30, 2018

Study Completion (Actual)

March 30, 2018

Study Registration Dates

First Submitted

July 24, 2017

First Submitted That Met QC Criteria

July 27, 2017

First Posted (Actual)

July 31, 2017

Study Record Updates

Last Update Posted (Actual)

April 4, 2018

Last Update Submitted That Met QC Criteria

April 3, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 2017-8872

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Deprescribing

Clinical Trials on rPATD Questionnaire

3
Subscribe